CAS 194861-70-6: (5alpha,8xi,9xi,12alpha,13xi,14beta)-12-hydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,5,10,14-pentamethylgonan-3-yl 2-O-(6-O-acetyl-beta-D-glucopyranosyl)-beta-D-glucopyranoside

Ginsenoside Rs3 induce apoptosis, is related to the elevations of p53 and p21WAF1 in the cells.

Ginsenoside RS3 is a bioactive compound, which is a natural product derived from the roots of the ginseng plant. It is classified as a saponin, a type of glycoside widely known for its diverse biological activities. Ginsenosides are the primary active components of ginseng, contributing to its medicinal properties. The mode of action of Ginsenoside RS3 involves modulation of various cellular pathways, including anti-inflammatory and antioxidant mechanisms. It has been shown to influence gene expression and protein activity, affecting multiple signaling cascades. These biochemical interactions are responsible for its neuroprotective, cardioprotective, and anticancer properties, making ginsenosides a subject of interest in therapeutic research. The uses and applications of Ginsenoside RS3 are vast, particularly in pharmacological research. It is explored for its potential in treating neurodegenerative diseases, cardiovascular disorders, and certain types of cancer. Due to its antioxidative properties, it also finds applications in studies investigating aging and related metabolic syndromes. Ginsenoside RS3 is continually investigated to better understand its comprehensive role in disease prevention and health promotion.